- Home
- PLTK vs VIR Comparison
PLTK vs VIR Comparison
Compare PLTK & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTK | VIR |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PLTK | VIR |
|---|---|---|
| Price | $3.83 | $9.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $5.04 | ★ $19.43 |
| AVG Volume (30 Days) | 1.7M | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 11.46% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,755,400,000.00 | $68,556,000.00 |
| Revenue This Year | $2.60 | $270.22 |
| Revenue Next Year | $2.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $2.64 | $4.16 |
| 52 Week High | $4.93 | $11.66 |
Technical Indicators
Market Signals| Indicator | PLTK | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 56.63 | 54.17 |
| Support Level | $3.28 | $8.40 |
| Resistance Level | $3.83 | $10.25 |
| Average True Range (ATR) | 0.21 | 0.51 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 54.76 | 57.39 |
Price Performance
Historical ComparisonAbout PLTK Playtika Holding Corp.
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.